Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Granu Fink femina
- Development stage
- Unknown
- Lead developer
- Perrigo
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
GRANU FINK femina is a traditional herbal phytomedicine developed by Omega Pharma (a Perrigo company) for the management of overactive bladder (OAB) and urinary incontinence, specifically in women. The formulation consists of a triple combination of active botanical extracts: Uromedic pumpkin seeds (*Cucurbita pepo*), women's sumac (*Rhus coriaria*), and hops (*Humulus lupulus*). It is designed to strengthen the bladder-sphincter system and calm the detrusor muscle, thereby reducing symptoms such as urinary urgency, frequent urination, and bladder irritation. As a traditional herbal medicinal product (THMP) registered in Germany, its approval is based on long-standing traditional use rather than modern clinical trials, although real-world observational data supports its efficacy and tolerability profile.
- Brand names
- Granu Fink femina
- Other names
- pumpkin seed oil + fragrant sumach bark extract + hop strobile extract
Beyond the preview
Go deeper on Granu Fink femina.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granu Fink femina.